You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: March 5, 2021

DrugPatentWatch Database Preview

COSOPT PF Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cosopt Pf patents expire, and when can generic versions of Cosopt Pf launch?

Cosopt Pf is a drug marketed by Akorn and is included in one NDA.

The generic ingredient in COSOPT PF is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.

Summary for COSOPT PF
Drug patent expirations by year for COSOPT PF
Drug Sales Revenue Trends for COSOPT PF

See drug sales revenues for COSOPT PF

Recent Clinical Trials for COSOPT PF

Identify potential brand extensions & 505(b)(2) entrants

University of FloridaPhase 1
Mid Atlantic RetinaPhase 2/Phase 3
Wills EyePhase 2/Phase 3

See all COSOPT PF clinical trials

US Patents and Regulatory Information for COSOPT PF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn COSOPT PF dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 202667-001 Feb 1, 2012 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.